Showing results (391-400 of 567) with videos related to
Sort By:
Pageof 57
Biomaterials|April 7, 2007
The performance of poly-epsilon-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4L Savarino, N Baldini, M Greco, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 19, 2020
Coronary microvascular dysfunction in patients with psoriasisBrittany Weber, Lourdes M Perez-Chada, Sanjay Divakaran, et al.Rheumatology (Oxford, England)|February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritisDennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.Journal of the American Academy of Dermatology|April 2, 2013
Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosusJoseph F Merola, Stephen D Prystowsky, Christina Iversen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2017
Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3)A Menter, R B Warren, R G Langley, et al.Rheumatology and Therapy|July 24, 2020
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population SurveyWilliam Tillett, Joseph F Merola, Diamant Thaçi, et al.Dermatology and Therapy|July 15, 2024
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic DermatitisJennifer Soung, Vivian Laquer, Joseph F Merola, et al.Clinical and Experimental Dermatology|February 6, 2016
Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosisD Timerman, P M Devlin, V E Nambudiri, et al.Rheumatology and Therapy|March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three IndicationsJoseph F Merola, Iain B McInnes, Atul A Deodhar, et al.Pageof 57